Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | GABRP | O00591 | 2/20 | 0.40 |
| ▸ | GABRD | O14764 | 2/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.40 |
| ▸ | GABRE | P78334 | 2/20 | 0.40 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.40 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.40 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL621545 | 0.91 | ALDH1A1 (0.48) | ALDH1A1CA2CYP3A4TSHRMAPK1 | |
| SCHEMBL7102381 | 0.88 | ALDH1A1 (0.47) | ALDH1A1CA2CYP3A4TSHRMAPK1 | |
| SCHEMBL18485499 | 0.86 | ALDH1A1 (0.43) | ALDH1A1CA2CYP3A4TSHRMAPK1 | |
| SCHEMBL7771000 | 0.85 | ALDH1A1 (0.47) | ALDH1A1CA2CYP3A4TSHRMAPK1 | |
| SCHEMBL29757688 | 0.84 | PRSS1 (0.44) | ALDH1A1CA2CYP3A4TSHRMAPK1 | |
| SCHEMBL27208715 | 0.84 | PPARA (0.47) | ALDH1A1CA2CYP3A4TSHRMAPK1 | |
| SCHEMBL25380587 | 0.83 | ALDH1A1 (0.42) | ALDH1A1CA2CYP3A4TSHRMAPK1 | |
| SCHEMBL31500833 | 0.83 | PPARA (0.49) | ALDH1A1CA2CYP3A4TSHRMAPK1 | |
| SCHEMBL27208712 | 0.83 | PPARA (0.49) | ALDH1A1CA2CYP3A4TSHRMAPK1 | |
| SCHEMBL27208854 | 0.83 | PPARA (0.49) | ALDH1A1CA2CYP3A4TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115697281-B | Shear thinning cosmetic composition | ELC管理有限责任公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-115701969-A | Novel encapsulated cosmetic compositions and uses thereof | ELC管理有限责任公司 | 2023-02-14 | — | — | CN | disclosed |
| CN-115697281-A | Shear thinning cosmetic composition | ELC管理有限责任公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-115135199-A | Method and system for multi-layer cosmetic pad and use thereof | ELC 管理有限责任公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-106715463-B | Glycated peptide compositions and uses thereof | 苏塞克斯研究实验室 | 2020-10-16 | — | — | CN | disclosed |
| CN-108348560-A | Include the composition and its application method of silymarin and sulphur hydrocarbyl ether cyclodextrin | 锡德克斯药物公司 | 2018-07-31 | — | — | CN | disclosed |
| CN-102166166-B | Method and application using compounds from fetal cells and tissues to improve skin condition | SOO CHIA | 2013-08-14 | — | — | CN | disclosed |
| CN-102166166-A | Method and application using compounds from fetal cells and tissues to improve skin condition | CHIA SOO | 2011-08-31 | — | — | CN | disclosed |
| CN-1744821-B | Methods of using compounds from fetal cells and tissues to improve skin conditions and uses thereof | CHIA SOO | 2011-05-18 | — | — | CN | disclosed |
| CN-1893911-B | Formula including tetrapeptide and tripeptide mixture | SEDERMA SA | 2010-12-29 | — | — | CN | disclosed |
| CN-1893911-A | Formula including tetrapeptide and tripeptide mixture | SEDERMA SA (FR) | 2007-01-10 | — | — | CN | disclosed |
| CN-1744821-A | Methods of using compounds from fetal cells and tissues to improve skin conditions and compositions thereof | CHIA SOO (US) | 2006-03-08 | — | — | CN | disclosed |